| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | |
|---|
| What is an ATC-Code? | ATC-Overview |
|
| | | IP | CI | | Emselex 7.5 mg - T | 14 Tablet(s) | 10.20 | 27.50 | 10 % | | Delayed release tablets: Darifenacinum 7.5 mg | CPS Cito Pharma Services GmbH | B / SL | FB | G |
| | | IP | CI | | Emselex 7.5 mg - T | 56 Tablet(s) | 40.77 | 60.75 | 10 % | | Delayed release tablets: Darifenacinum 7.5 mg | CPS Cito Pharma Services GmbH | B / SL | FB | G |
| | | IP | CI | | Emselex 15 mg - T | 14 Tablet(s) | 10.20 | 27.50 | 10 % | | Delayed release tablets: Darifenacinum 15 mg | CPS Cito Pharma Services GmbH | ● B / SL | FB | G |
| | | IP | CI | | Emselex 15 mg - T | 56 Tablet(s) | 40.77 | 60.75 | 10 % | | Delayed release tablets: Darifenacinum 15 mg | CPS Cito Pharma Services GmbH | B / SL | FB | G |
|
| | SIP | IP | CI | | Toviaz, Retardtabletten 4 mg | 14 Tablet(s) | 9.92 | 27.15 | 10 % | | Fesoterodini Fumaras 4 mg | Pfizer AG | B / SL / SO | FB | G |
| | SIP | IP | CI | | Toviaz, Retardtabletten 4 mg | 84 Tablet(s) | 57.92 | 79.10 | 10 % | | Fesoterodini Fumaras 4 mg | Pfizer AG | B / SL / SO | FB | G |
| | SIP | IP | CI | | Toviaz, Retardtabletten 8 mg - T | 14 Tablet(s) | 10.39 | 27.65 | 10 % | | Fesoterodini Fumaras 8 mg | Pfizer AG | B / SL / SO | FB | G |
| | SIP | IP | CI | | Toviaz, Retardtabletten 8 mg - T | 84 Tablet(s) | 60.91 | 82.30 | 10 % | | Fesoterodini Fumaras 8 mg | Pfizer AG | B / SL / SO | FB | G |
| | | IP | CI | | Fesoterodin Spirig HC retard 4 mg | 14 | 9.02 | 26.25 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 4 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Fesoterodin Spirig HC retard 4 mg | 84 | 52.66 | 73.70 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 4 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Fesoterodin Spirig HC retard 8 mg | 14 | 9.45 | 26.70 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 8 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Fesoterodin Spirig HC retard 8 mg | 84 | 55.38 | 76.65 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 8 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Fesoterodin Zentiva 4 mg | 14 | 9.02 | 26.25 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 4 mg | Helvepharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Fesoterodin Zentiva 4 mg | 84 | 52.66 | 73.70 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 4 mg | Helvepharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Fesoterodin Zentiva 8 mg | 14 | 9.45 | 26.70 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 8 mg | Helvepharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Fesoterodin Zentiva 8 mg | 84 | 55.38 | 76.65 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 8 mg | Helvepharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Fesoterodin-Mepha 4 mg | 14 | 9.02 | 26.25 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 4 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Fesoterodin-Mepha 4 mg | 84 | 52.66 | 73.70 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 4 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Fesoterodin-Mepha 8 mg | 14 | 9.45 | 26.70 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 8 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Fesoterodin-Mepha 8 mg | 84 | 55.38 | 76.65 | 10 % | | Delayed release tablets: Fesoterodini Fumaras 8 mg | Mepha Pharma AG | B / SL / SG | FB | G |
|
| L | | IP | CI | | Caverject DC 10 | 2 syringe(s) | 16.39 | 34.25 | 10 % | | Injection preparation: Alprostadilum 10 µg | Pfizer AG | A / SL | FB | G |
| L | | IP | CI | | Caverject 10 ug | Durchstechflasche(n) | 9.65 | 26.90 | 10 % | | Lyophilisate and solvent: Alprostadilum 10 µg | Pfizer AG | A / SL | FB | G |
| L | | IP | CI | | Caverject DC 20 | 2 syringe(s) | 27.78 | 46.65 | 10 % | | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung in einer Fertigspritze: Alprostadilum 20 µg | Pfizer AG | A / SL | FB | G |
| | | IP | CI | | Caverject 20 ug | Durchstechflasche(n) | | | k.A. | | Lyophilisate and solvent: Alprostadilum 20 µg | Pfizer AG | A | FB | G |
|
| | | IP | CI | | Spedra 50 mg | 4 Tablet(s) | | | k.A. | | Tablets: Avanafilum 50 mg | Curatis AG | ● B | FB | G |
| | | IP | CI | | Spedra 50 mg | 12 Tablet(s) | | | k.A. | | Tablets: Avanafilum 50 mg | Curatis AG | B | FB | G |
| | | IP | CI | | Spedra 100 mg | 4 Tablet(s) | | | k.A. | | Tablets: Avanafilum 100 mg | Curatis AG | B | FB | G |
| | | IP | CI | | Spedra 100 mg | 12 Tablet(s) | | | k.A. | | Tablets: Avanafilum 100 mg | Curatis AG | B | FB | G |
| | | IP | CI | | Spedra 200 mg | 4 Tablet(s) | | | k.A. | | Tablets: Avanafilum 200 mg | Curatis AG | B | FB | G |
| | | IP | CI | | Spedra 200 mg | 12 Tablet(s) | | | k.A. | | Tablets: Avanafilum 200 mg | Curatis AG | B | FB | G |
| | | IP | CI | | Spedra 50 mg | 8 Tablet(s) | | | k.A. | | Tablets: Avanafilum 50 mg | Curatis AG | B | FB | G |
| | | IP | CI | | Spedra 100 mg | 2 Tablet(s) | | | k.A. | | Tablets: Avanafilum 100 mg | Curatis AG | B | FB | G |
| | | IP | CI | | Spedra 100 mg | 8 Tablet(s) | | | k.A. | | Tablets: Avanafilum 100 mg | Curatis AG | B | FB | G |
| | | IP | CI | | Spedra 200 mg | 8 Tablet(s) | | | k.A. | | Tablets: Avanafilum 200 mg | Curatis AG | B | FB | G |
|
| | | IP | CI | Ph | Cystinol | 40 Tablet(s) | | | k.A. | | | Medinova AG | D | FB | G |
| | | | CI | Ph | Sidroga Blasen- und Nierentee | 20 x 1.3 g | | | k.A. | | | Uriach Switzerland AG | D | FB | G |
| | | | CI | PhCM | Amavita Nieren- und Blasendragées | 40 | | | k.A. | | Coated tablets: 3 Active Agents | Amavita Health Care AG | D | FB | G |
| | | | CI | PhCM | Coop Vitality Nieren- und Blasendragées | 40 | | | k.A. | | Coated tablets: 3 Active Agents | Coop Vitality Health Care GmbH | D | FB | G |
| | | | CI | Ph | Nieren- und Blasendragées S | 20 Dragée(s) | | | k.A. | | Coated tablets: 3 Active Agents | Hänseler AG | D | FB | G |
| | | | CI | Ph | Nieren- und Blasendragées S | 40 Dragée(s) | | | k.A. | | Coated tablets: 3 Active Agents | Hänseler AG | D | FB | G |
| | | | CI | Ph | Nieren- und Blasendragées S | 60 Dragée(s) | | | k.A. | | Coated tablets: 3 Active Agents | Hänseler AG | D | FB | G |
| | | | CI | CM | SUN STORE Nieren- und Blasendragées | 40 | | | k.A. | | Coated tablets: 3 Active Agents | Sun Store Health Care AG | D | FB | G |
| | | IP | CI | | Arkocaps Busserole nouvelle formule | 45 | | | k.A. | | Capsules: Uvae ursi Folii Pulvis 350 mg | Arko Diffusion AG | D | FB | G |
| | | | CI | Ph | Arkocaps Orthosiphon 325 mg | 45 Capsule(s) | | | k.A. | | Capsules: Orthosiphonis Pulvis 325 mg | Arko Diffusion AG | D | FB | G |
| | | | CI | Ph | Arkocaps Orthosiphon 325 mg | 150 Capsule(s) | | | k.A. | | Capsules: Orthosiphonis Pulvis 325 mg | Arko Diffusion AG | D | FB | G |
| | | IP | CI | Ph | Granufink femina | 60 Capsule(s) | | | k.A. | | Capsules: 3 Active Agents | Perrigo Schweiz AG | D | FB | G |
| | | IP | CI | Ph | Granufink femina | 120 Capsule(s) | | | k.A. | | Capsules: 3 Active Agents | Perrigo Schweiz AG | D | FB | G |
| | | IP | CI | | Uro-Vaxom | 3 x 10 Capsule(s) | | | k.A. | | Capsules: Escherichiae coli Lysati Filtratum 6 mg | OM Pharma SA | B | FB | G |
| | | IP | CI | | Uro-Vaxom | 9 x 10 Capsule(s) | | | k.A. | | Capsules: Escherichiae coli Lysati Filtratum 6 mg | OM Pharma SA | B | FB | G |
| | | | CI | Ph | Sidroga Birkenblätter | 20 x 1.5 g | | | k.A. | | Arzneitee: Betulae Folium (Betula Pendula roth und / oder Betula Pubescens ehrh., Folium) 1.5 g | Uriach Switzerland AG | D | FB | G |
| | | | CI | Ph | Sidroga Brennnesselblätter | 20 1 Teebeutel à 1.5 g | | | k.A. | | Arzneitee: Urticae Folium (Urtica Dioica l. Und/oder Urtica Urens l., Folium) 1.5 g | Uriach Switzerland AG | D | FB | G |
| | | | CI | Ph | Sidroga Bärentraubenblätter | 20 1 Teebeutel à 2 g | | | k.A. | | Arzneitee: Uvae ursi Folium (Arctostaphylos Uva-Ursi (L.) Spreng) 2 g | Uriach Switzerland AG | D | FB | G |
| | | | CI | Ph | Sidroga Harntee | 20 1 Teebeutel à 1.5 g | | | k.A. | | Arzneitee: 4 Active Agents | Uriach Switzerland AG | D | FB | G |
| | | | CI | Ph | Sidroga Schachtelhalm | 20 1 Teebeutel à 2 g | | | k.A. | | Arzneitee: Equiseti Herba (Equisetum Arvense l., Herba) 2 g | Uriach Switzerland AG | D | FB | G |
| | | IP | CI | | Canephron | 30 | | | k.A. | | überzogene Tabletten: 3 Active Agents | Biomed AG | D | FB | G |
| | | | | PhCM | Floramed Blasentee | 20 1 Sachet(s) à 1.5 g | | | k.A. | | Chopped herbs: 5 Active Agents | Morga AG | E | FB | G |
| | | | | Ph | Morga Blasentee | 20 1 Sachet(s) à 1.5 g | | | k.A. | | Chopped herbs: 5 Active Agents | Morga AG | E | FB | G |
| | | | | | Angomed | 75 | | | k.A. | | Coated tablets: 2 Active Agents | Zeller Medical AG | D | FB | G |
| | | | | PhCM | Swidro Nieren- und Blasendragées | 20 Dragée(s) | | | k.A. | | Coated tablets: 3 Active Agents | Hänseler AG | D | FB | G |
| | | | | PhCM | Swidro Nieren- und Blasendragées | 40 | | | k.A. | | Coated tablets: 3 Active Agents | Hänseler AG | D | FB | G |
| | | IP | CI | Ph | Granufink femina | 30 Capsule(s) | | | k.A. | | Capsules: 3 Active Agents | Perrigo Schweiz AG | D | FB | G |
| | | | | Ph | Klostergarten Blasentee Benedictus | 20 x 1.5 g | | | k.A. | | Arzneitee: 7 Active Agents | Migros- Genossenschafts-Bund | E | FB | G |
|
| | | IP | CI | | PRILIGY | 3 Tablet(s) | | | k.A. | | Coated tablets: Dapoxetinum 30 mg | Curatis AG | B | FB | G |
| | | IP | CI | | PRILIGY | 6 Tablet(s) | | | k.A. | | Coated tablets: Dapoxetinum 30 mg | Curatis AG | B | FB | G |
|
| L | | IP | CI | | Xatral uno | 90 Tablet(s) | 39.59 | 59.25 | 10 % | | Delayed release tablets: Alfuzosini Hydrochloridum 10 mg | Sanofi-Aventis (Suisse) SA | B / SL / SO | FB | G |
| | | IP | CI | | Alfuzosin axapharm | 30 Tablet(s) | 13.19 | 30.75 | 10 % | | Delayed release tablets: Alfuzosini Hydrochloridum 10 mg | axapharm ag | B / SL / SG | FB | G |
| | | IP | CI | | Alfuzosin axapharm | 90 Tablet(s) | 36.00 | 55.55 | 10 % | | Delayed release tablets: Alfuzosini Hydrochloridum 10 mg | axapharm ag | B / SL / SG | FB | G |
| | | IP | CI | | Alfuzosin-Mepha retard | 10 | 4.62 | 14.25 | 10 % | | Delayed release tablets: Alfuzosini Hydrochloridum 10 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Alfuzosin-Mepha retard | 30 | 13.14 | 30.70 | 10 % | | Delayed release tablets: Alfuzosini Hydrochloridum 10 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Alfuzosin-Mepha retard | 90 | 36.00 | 55.55 | 10 % | | Delayed release tablets: Alfuzosini Hydrochloridum 10 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Alfuzosine Uno Zentiva 10 mg | 10 Tablet(s) | 4.62 | 14.25 | 10 % | | Delayed release tablets: Alfuzosini Hydrochloridum 10 mg | Helvepharm AG | ● B / SL / SG | FB | G |
| | | IP | CI | | Alfuzosine Uno Zentiva 10 mg ‐ I | 30 Tablet(s) | 13.14 | 30.70 | 10 % | | Delayed release tablets: Alfuzosini Hydrochloridum 10 mg | Helvepharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Alfuzosine Uno Zentiva 10 mg ‐ I | 90 Tablet(s) | 36.00 | 55.55 | 10 % | | Delayed release tablets: Alfuzosini Hydrochloridum 10 mg | Helvepharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Alfuzosin axapharm | 10 Tablet(s) | 4.71 | 14.35 | k.A. | | Delayed release tablets: Alfuzosini Hydrochloridum 10 mg | axapharm ag | B | FB | G |
| | | IP | CI | | Xatral uno | 10 Tablet(s) | 5.26 | 14.90 | k.A. | | Delayed release tablets: Alfuzosini Hydrochloridum 10 mg | Sanofi-Aventis (Suisse) SA | B | FB | G |
| | | IP | CI | | Xatral uno | 30 Tablet(s) | 14.14 | 31.75 | k.A. | | Delayed release tablets: Alfuzosini Hydrochloridum 10 mg | Sanofi-Aventis (Suisse) SA | B | FB | G |
| | | IP | CI | | Xatral 2,5 mg | 60 Tablet(s) | | | k.A. | | Coated tablets: Alfuzosini Hydrochloridum 2.5 mg | Sanofi-Aventis (Suisse) SA | B | FB | G |
| | | | | | Alfuzosin Spirig HC retard 10 mg | 10 | | | k.A. | | Delayed release tablets: Alfuzosini Hydrochloridum 10 mg | Spirig HealthCare AG | B | FB | G |
| | | | | | Alfuzosin Spirig HC retard 10 mg | 30 | | | k.A. | | Delayed release tablets: Alfuzosini Hydrochloridum 10 mg | Spirig HealthCare AG | B | FB | G |
| | | | | | Alfuzosin Spirig HC retard 10 mg | 90 | | | k.A. | | Delayed release tablets: Alfuzosini Hydrochloridum 10 mg | Spirig HealthCare AG | B | FB | G |
|
| | | IP | CI | | Proscar | 30 | 19.65 | 37.45 | 20 % | | Coated tablets: Finasteridum 5 mg | Organon GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Proscar | 105 | 67.48 | 88.90 | 20 % | | Coated tablets: Finasteridum 5 mg | Organon GmbH | B / SL / SO | FB | G |
| | | IP | | | Finasterax | 28 Tablet(s) | 13.61 | 31.25 | 10 % | | Coated tablets: Finasteridum 5 mg | Drossapharm AG | B / SL / SG | FB | G |
| | | IP | | | Finasterax | 98 Tablet(s) | 52.49 | 73.55 | 10 % | | Coated tablets: Finasteridum 5 mg | Drossapharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Finasterid Sandoz 5 | 30 Tablet(s) | 16.07 | 33.80 | 10 % | | Coated tablets: Finasteridum 5 mg | Sandoz Pharmaceuticals AG | ● B / SL / SG | FB | G |
| | | IP | CI | | Finasterid Sandoz 5 | 100 Tablet(s) | 53.56 | 74.65 | 10 % | | Coated tablets: Finasteridum 5 mg | Sandoz Pharmaceuticals AG | ● B / SL / SG | FB | G |
| | | IP | CI | | Finasterid Spirig HC 5 | 28 Tablet(s) | 13.51 | 31.15 | 10 % | | Coated tablets: Finasteridum 5 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Finasterid Spirig HC 5 | 98 Tablet(s) | 52.49 | 73.55 | 10 % | | Coated tablets: Finasteridum 5 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Finasterid-Mepha 5 | 30 Tablet(s) | 15.82 | 33.55 | 10 % | | Coated tablets: Finasteridum 5 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Finasterid-Mepha 5 | 100 Tablet(s) | 53.56 | 74.65 | 10 % | | Coated tablets: Finasteridum 5 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | | | Finasterid Streuli 5 | 28 Tablet(s) | 15.05 | 33.70 | k.A. | | Coated tablets: Finasteridum 5 mg | Streuli Pharma AG | B | FB | G |
| | | IP | | | Finasterid Streuli 5 | 98 Tablet(s) | 52.49 | 76.65 | k.A. | | Coated tablets: Finasteridum 5 mg | Streuli Pharma AG | B | FB | G |
| | | IP | CI | | Finasterid-Teva 5 mg | 30 Coated tablet(s) | 14.05 | 28.45 | k.A. | | | Teva Pharma AG | B | FB | G |
| | | IP | CI | | Finasterid-Teva 5 mg | 100 Coated tablet(s) | 53.56 | 77.90 | k.A. | | | Teva Pharma AG | B | FB | G |
|
| | | IP | CI | | Avodart | 30 Capsule(s) | 18.58 | 28.60 | 10 % | | Soft capsules: Dutasteridum | GlaxoSmithKline AG | B / SL / SO | FB | G |
| | | IP | CI | | Avodart | 90 Capsule(s) | 55.67 | 74.50 | 10 % | | Soft capsules: Dutasteridum | GlaxoSmithKline AG | B / SL / SO | FB | G |
| | | IP | CI | | Dutasterid Spirig HC 0.5mg | 30 | 5.47 | 15.15 | 10 % | | Soft capsules: Dutasteridum | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Dutasterid Spirig HC 0.5mg | 90 | 16.47 | 34.30 | 10 % | | Soft capsules: Dutasteridum | Spirig HealthCare AG | B / SL / SG | FB | G |
|
| | | IP | CI | Ph | Granufink Prosta forte | 40 Capsule(s) | | | k.A. | | Capsules: Cucurbitae Peponis Seminis Extracum Spissum (Cucurbita pepo l. Convar. Citrullina I. greb. var. Styriaca I. greb., Semen) 500 mg | Perrigo Schweiz AG | D | FB | G |
| | | IP | CI | Ph | Granufink Prosta forte | 80 Capsule(s) | | | k.A. | | Capsules: Cucurbitae Peponis Seminis Extracum Spissum (Cucurbita pepo l. Convar. Citrullina I. greb. var. Styriaca I. greb., Semen) 500 mg | Perrigo Schweiz AG | D | FB | G |
| | | IP | CI | Ph | Granufink Prosta forte | 140 Capsule(s) | | | k.A. | | Capsules: Cucurbitae Peponis Seminis Extracum Spissum (Cucurbita pepo l. Convar. Citrullina I. greb. var. Styriaca I. greb., Semen) 500 mg | Perrigo Schweiz AG | D | FB | G |